Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Board/Management Information 2023

Nov 16, 2023

60507_rns_2023-11-16_ca02cd99-3013-42f4-913b-18026ad29ca1.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

November 16, 2023

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation regarding Appointment of Senior Management Personnel of the Company.

Ref.: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company hereby wishes to inform that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has appointed Ms. Aditi Mehta as Category Lead, Vaccines effective December 1, 2023. Accordingly, Ms. Aditi Mehta shall be a Senior Management Personnel effective the said date.

Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and List/Comp/14/2018-19 dated June 20, 2018, are enclosed as Annexure A.

Request you to please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2023.11.16 17:14:54 +05'30' Prajeet Nair

Director – Corporate Services & Company Secretary

Encl: A/a

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in

Annexure A Additional details of Ms. Aditi Mehta

Sr. no Particulars Details
1. Reasons for change Fresh Appointment
2. Date of Appointment and Term December 1, 2023
3. Affirmation as per List/Comp/14/2018-
19 dated June 20, 2018
Not Applicable
4. Relationship
inter-se
Directors
/ Key Managerial Personnel / Senior
Management Personnel

Ms. Aditi Mehta is not related to any of the
Directors/Key
Managerial
Personnel
/
Senior Management Personnel.
5. Number of Shares held in the Company
Nil
6. Brief Profile Ms. Aditi Mehta is a Gold Medalist in
Bachelor of Pharmacy from K.M Kundnani
College of Pharmacy, Mumbai.
Ms.
Aditi
Mehta
is
a
seasoned
pharmaceutical professional with over 13
years of experience in pharmaceutical
marketing, strategy & research. Ms. Mehta
had a decade long stint with Pfizer Products
India Pvt. Ltd., (Pfizer Inc.’s wholly owned
subsidiary in India) where she held positions
of increasing responsibilities. In her role as
Category Lead for Oncology business, she
was responsible for the development and
execution of the strategy for the Oncology
portfolio for India market. Prior to this,
Ms. Mehta had a two-year stint with Bristol
Myers Squibb as a Business Analyst.
Ms. Mehta is proud receipt of various
accolades and awards, including the
Medico-Marketing Excellence Award 2017
by Pfizer India Country Leadership, Pfizer
Global Commercial Award in 2019 for
Breast Cancer Access initiatives in India,
e4M Health & Wellness Marketing Award
2023 for World Cancer Day Awareness
Campaign. Most recently, she has also been
selected among the Top 100 Inspiring
Women Leaders in Pfizer.